title: Elevations in Serum Creatinine With Tenofovir-Based HIV Pre-Exposure Prophylaxis: A Meta-Analysis of Randomized Placebo-Controlled Trials.
authors.affiliation: *Division of Nephrology, Department of Medicine, University at Buffalo, Buffalo, NY †Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY ‡Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT §Department of Nephrology-Transplantation-Dialysis, Bordeaux Hospital, Bordeaux, France ‖Gladstone Institutes, University of California, San Francisco and the San Francisco AIDS Foundation, San Francisco, CA ¶Department of Epidemiology, University of Washington, Seattle, WA #Departments of Global Health, Medicine, and Epidemiology, University of Washington, Seattle, WA.
authors.forename: Rabi
authors.initials: R
authors.lastname: Yacoub
authors.forename: Girish N
authors.initials: GN
authors.lastname: Nadkarni
authors.forename: Damian
authors.initials: D
authors.lastname: Weikum
authors.forename: Ioannis
authors.initials: I
authors.lastname: Konstantinidis
authors.forename: Anna
authors.initials: A
authors.lastname: Boueilh
authors.forename: Robert M
authors.initials: RM
authors.lastname: Grant
authors.forename: Kenneth K
authors.initials: KK
authors.lastname: Mugwanya
authors.forename: Jared M
authors.initials: JM
authors.lastname: Baeten
authors.forename: Christina M
authors.initials: CM
authors.lastname: Wyatt
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D003404:Creatinine / Q000097:blood*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D065129:Pre-Exposure Prophylaxis; D016032:Randomized Controlled Trials as Topic; D000068698:Tenofovir / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*
chemical_list: D019380:Anti-HIV Agents; D000068698:Tenofovir; D003404:Creatinine